AP – Peregrine Pharmaceuticals Inc. said Thursday it cut its 2010 fiscal second-quarter loss nearly in half as revenue from manufacturing services and government payments for the antivirus drug candidate bavituximab increased sharply.
AP – Peregrine Pharmaceuticals Inc. said Thursday it cut its 2010 fiscal second-quarter loss nearly in half as revenue from manufacturing services and government payments for the antivirus drug candidate bavituximab increased sharply.